Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Roivant Sciences leads the 154 health care companies ranked by P/S ratio, at 3418, ahead of Dianthus Therapeutics (2346) and CG Oncology (1811). Figures as of 19 Nov 2026, 21:45 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- First
- Roivant Sciences3418
- Median
- 4.2
- Combined market value
- HUF 3033.56T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Roivant SciencesROIV · Health Care | 3418 | HUF 9.6T | HUF 13,247.96 | 0.59% up | 91% up | ||
| 2 | Dianthus TherapeuticsDNTH · Health Care | 2346 | HUF 1.62T | HUF 28,845.59 | 1.01% up | 108% up | ||
| 3 | CG OncologyCGON · Health Care | 1811 | HUF 2.49T | HUF 27,849.28 | 2.38% up | 97% up | ||
| 4 | CRISPR TherapeuticsCRSP · Health Care | 1076 | HUF 1.28T | HUF 13,237.76 | 3.14% down | 18% down | ||
| 5 | Kymera TherapeuticsKYMR · Health Care | 260 | HUF 3.47T | HUF 40,597.38 | 1.44% down | 87% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | 176 | HUF 2.75T | HUF 42,171.76 | 2.47% down | 51% up | ||
| 7 | CytokineticsCYTK · Health Care | 81.4 | HUF 2.44T | HUF 17,498.46 | 0.27% up | 19% down | ||
| 8 | ImmunityBioIBRX · Health Care | 61.7 | HUF 2.38T | HUF 2,234.06 | 1.94% down | 232% up | ||
| 9 | InsmedINSM · Health Care | 52.3 | HUF 10.78T | HUF 49,122.18 | 20.58% up | 40% down | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | HUF 2.75T | HUF 39,716.67 | 1.88% down | 18% up | ||
| 11 | ModernaMRNA · Health Care | 41.5 | HUF 27.43T | HUF 67,780.17 | 1.29% up | 780% up | ||
| 12 | GRAILGRAL · Health Care | 32.0 | HUF 1.6T | HUF 35,649.79 | 2.68% up | 19% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | 30.3 | HUF 5.18T | HUF 26,584.33 | 0.22% up | 21% up | ||
| 14 | WatersWAT · Health Care | 28.3 | HUF 30.51T | HUF 155,221.46 | 2.06% down | 23% up | ||
| 15 | GlaukosGKOS · Health Care | 27.8 | HUF 4.79T | HUF 80,963.52 | 2.15% up | 145% up | ||
| 16 | Krystal BiotechKRYS · Health Care | 24.1 | HUF 3.18T | HUF 107,391.43 | 0.15% up | 54% up | ||
| 17 | HeartflowHTFL · Health Care | 22.3 | HUF 1.33T | HUF 15,175.99 | 2.75% down | 66% up | ||
| 18 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | HUF 1.95T | HUF 97,571.08 | 3.94% down | 50% up | ||
| 19 | Ascendis PharmaASND · Health Care | 21.0 | HUF 5.71T | HUF 87,036.64 | 5.32% down | 29% up | ||
| 20 | Twist BioscienceTWST · Health Care | 20.2 | HUF 2.59T | HUF 37,955.26 | 4.07% down | 346% up | ||
| 21 | Guardant HealthGH · Health Care | 20.1 | HUF 6.7T | HUF 49,506.42 | 0.31% up | 45% up | ||
| 22 | Eli LillyLLY · Health Care | 18.5 | HUF 409.24T | HUF 459,434.84 | 2.29% down | 33% up | ||
| 23 | NateraNTRA · Health Care | 18.2 | HUF 14.3T | HUF 98,584.40 | 0.15% up | 28% up | ||
| 24 | Adaptive BiotechnologiesADPT · Health Care | 16.4 | HUF 1.54T | HUF 9,538.12 | 1.44% down | 74% up | ||
| 25 | Royalty PharmaRPRX · Health Care | 16.4 | HUF 13.24T | HUF 23,027.51 | 1.38% down | 79% up | ||
| 26 | TG TherapeuticsTGTX · Health Care | 15.9 | HUF 3.33T | HUF 22,061.80 | 1.88% down | 117% up | ||
| 27 | RepligenRGEN · Health Care | 14.7 | HUF 3.7T | HUF 57,905.41 | 1.38% down | 12% up | ||
| 28 | argenxARGX · Health Care | 14.3 | HUF 20.14T | HUF 320,331.28 | 0.08% up | 2% up | ||
| 29 | BillionToOneBLLN · Health Care | 14.1 | HUF 1.47T | HUF 30,671.61 | 1.46% down | 4% down | ||
| 30 | Intuitive SurgicalISRG · Health Care | 14.0 | HUF 48T | HUF 138,477.89 | 3.26% down | 24% down | ||
| 31 | IDEXX LaboratoriesIDXX · Health Care | 12.6 | HUF 18.48T | HUF 234,508.59 | 1.26% down | 1% up | ||
| 32 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | HUF 2.12T | HUF 32,477.22 | 3.27% up | 34% up | ||
| 33 | 10x GenomicsTXG · Health Care | 11.7 | HUF 2.57T | HUF 19,511.50 | 0.54% up | 247% up | ||
| 34 | Axsome TherapeuticsAXSM · Health Care | 11.2 | HUF 2.43T | HUF 46,136.63 | 1.25% up | 6% down | ||
| 35 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | HUF 44.89T | HUF 177,045.23 | 2.94% down | 27% up | ||
| 36 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | HUF 2.5T | HUF 31,805.64 | 1.59% down | 129% up | ||
| 37 | Edwards LifesciencesEW · Health Care | 9.8 | HUF 20.31T | HUF 35,323.36 | 1.28% down | 25% up | ||
| 38 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | HUF 3.13T | HUF 134,907.47 | 0.34% down | 27% down | ||
| 39 | Travere TherapeuticsTVTX · Health Care | 9.4 | HUF 1.58T | HUF 16,423.93 | 3.86% down | 45% up | ||
| 40 | Bio-TechneTECH · Health Care | 9.4 | HUF 3.88T | HUF 24,720.91 | 0.07% down | 24% up | ||
| 41 | Corcept TherapeuticsCORT · Health Care | 9.3 | HUF 2.42T | HUF 22,095.80 | 4.15% down | 10% down | ||
| 42 | West Pharmaceutical ServicesWST · Health Care | 9.0 | HUF 9.4T | HUF 134,890.47 | 1.81% down | 57% up | ||
| 43 | PenumbraPEN · Health Care | 9.0 | HUF 4.29T | HUF 108,816.20 | 0.18% down | 15% up | ||
| 44 | BeOne MedicinesONC · Health Care | 8.5 | HUF 15.52T | HUF 135,913.99 | 0.97% down | 16% up | ||
| 45 | GenmabGMAB · Health Care | 8.5 | HUF 10.77T | HUF 17,461.05 | 0.75% up | 70% up | ||
| 46 | Mettler-Toledo InternationalMTD · Health Care | 8.4 | HUF 11.54T | HUF 579,992.63 | 1.82% down | 24% up | ||
| 47 | AbbVieABBV · Health Care | 8.2 | HUF 170.42T | HUF 96,414.94 | 0.86% down | 25% up | ||
| 48 | Halozyme TherapeuticsHALO · Health Care | 7.6 | HUF 3.61T | HUF 31,637.32 | 2.88% down | 39% up | ||
| 49 | United TherapeuticsUTHR · Health Care | 7.5 | HUF 8.1T | HUF 190,116.36 | 3.16% down | 22% up | ||
| 50 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | HUF 2.1T | HUF 14,842.75 | 1.25% up | 13% up | ||
| 51 | Agilent TechnologiesA · Health Care | 7.1 | HUF 16.81T | HUF 59,622.61 | 1.12% down | 22% up | ||
| 52 | Gilead SciencesGILD · Health Care | 7.0 | HUF 70.24T | HUF 56,626.86 | 1.45% down | 35% up | ||
| 53 | Medpace HoldingsMEDP · Health Care | 7.0 | HUF 6.03T | HUF 215,578.56 | 1.99% down | 10% up | ||
| 54 | IlluminaILMN · Health Care | 7.0 | HUF 10.32T | HUF 68,230.73 | 4.45% down | 76% up | ||
| 55 | ExelixisEXEL · Health Care | 6.9 | HUF 5.46T | HUF 22,384.83 | 3.60% down | 63% up | ||
| 56 | Johnson & JohnsonJNJ · Health Care | 6.8 | HUF 218.68T | HUF 90,838.29 | 2.04% down | 34% up | ||
| 57 | Regeneron PharmaceuticalsREGN · Health Care | 6.7 | HUF 32.48T | HUF 313,972.53 | 2.35% down | 28% up | ||
| 58 | Caris Life SciencesCAI · Health Care | 6.5 | HUF 1.81T | HUF 6,304.34 | 4.92% down | 19% down | ||
| 59 | DanaherDHR · Health Care | 6.5 | HUF 54.44T | HUF 77,379.50 | 0.45% down | 3% up | ||
| 60 | AmgenAMGN · Health Care | 6.5 | HUF 80.71T | HUF 149,216.35 | 1.14% down | 32% up | ||
| 61 | DexComDXCM · Health Care | 6.4 | HUF 10.17T | HUF 27,267.81 | 2.82% down | 41% up | ||
| 62 | BioNTechBNTX · Health Care | 6.3 | HUF 6.86T | HUF 27,672.46 | 2.26% down | 14% down | ||
| 63 | HealthEquityHQY · Health Care | 6.1 | HUF 2.74T | HUF 33,113.10 | 0.07% up | 3% down | ||
| 64 | RevvityRVTY · Health Care | 5.9 | HUF 5.75T | HUF 51,546.66 | 0.55% down | 62% up | ||
| 65 | ResMedRMD · Health Care | 5.9 | HUF 11.33T | HUF 80,548.68 | 2.36% down | 1% down | ||
| 66 | Thermo Fisher ScientificTMO · Health Care | 5.7 | HUF 86.78T | HUF 234,202.55 | 0.58% down | 21% up | ||
| 67 | Neurocrine BiosciencesNBIX · Health Care | 5.5 | HUF 5.39T | HUF 53,246.86 | 3.85% down | 17% up | ||
| 68 | Alnylam PharmaceuticalsALNY · Health Care | 5.3 | HUF 6.73T | HUF 50,264.71 | 1.06% down | 66% down | ||
| 69 | AlkermesALKS · Health Care | 5.3 | HUF 2.64T | HUF 15,703.05 | 1.43% down | 66% up | ||
| 70 | NovartisNVS · Health Care | 5.2 | HUF 97.11T | HUF 51,420.85 | 2.57% down | 25% up | ||
| 71 | Merck & CoMRK · Health Care | 5.0 | HUF 111.33T | HUF 45,160.71 | 3.61% down | 45% up | ||
| 72 | QiagenQGEN · Health Care | 4.9 | HUF 3.48T | HUF 16,876.19 | 0.14% up | 9% up | ||
| 73 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | HUF 1.54T | HUF 9,255.89 | 0.62% down | 63% down | ||
| 74 | StrykerSYK · Health Care | 4.7 | HUF 40.53T | HUF 106,459.72 | 1.59% down | 12% down | ||
| 75 | AstraZenecaAZN · Health Care | 4.6 | HUF 92.51T | HUF 59,646.42 | 1.87% down | 1% up | ||
| 76 | IncyteINCY · Health Care | 4.6 | HUF 8.03T | HUF 39,400.43 | 1.64% down | 16% up | ||
| 77 | Lantheus HoldingsLNTH · Health Care | 4.3 | HUF 2.27T | HUF 34,718.08 | 0.10% up | 90% up | ||
| 78 | STERISSTE · Health Care | 4.2 | HUF 8.41T | HUF 86,628.59 | 1.85% down | 1% up | ||
| 79 | HaemoneticsHAE · Health Care | 4.1 | HUF 1.86T | HUF 40,930.61 | 2.03% down | 64% up | ||
| 80 | Abbott LaboratoriesABT · Health Care | 4.1 | HUF 61.17T | HUF 35,319.95 | 0.58% down | 16% down | ||
| 81 | Charles River Laboratories InternationalCRL · Health Care | 3.9 | HUF 5.34T | HUF 111,509.32 | 1.60% down | 106% up | ||
| 82 | Bio-Rad LaboratoriesBIO · Health Care | 3.8 | HUF 3.36T | HUF 124,964.70 | 0.72% down | 22% up | ||
| 83 | Novo NordiskNVO · Health Care | 3.7 | HUF 58.25T | HUF 13,217.35 | 1.42% down | 17% down | ||
| 84 | BiogenBIIB · Health Care | 3.7 | HUF 12.42T | HUF 84,034.09 | 1.70% down | 49% up | ||
| 85 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | HUF 4.05T | HUF 20,885.26 | 0.02% down | 17% up | ||
| 86 | LivaNovaLIVN · Health Care | 3.7 | HUF 1.72T | HUF 31,307.48 | 2.61% down | 77% up | ||
| 87 | MSA SafetyMSA · Health Care | 3.6 | HUF 2.31T | HUF 59,928.65 | 0.68% down | 16% up | ||
| 88 | LifeStance Health GroupLFST · Health Care | 3.6 | HUF 1.72T | HUF 4,536.13 | 3.12% down | 123% up | ||
| 89 | Jazz PharmaceuticalsJAZZ · Health Care | 3.6 | HUF 5.16T | HUF 80,402.46 | 4.57% down | 41% up | ||
| 90 | MedtronicMDT · Health Care | 3.5 | HUF 43.76T | HUF 34,211.42 | 0.11% down | 1% up | ||
| 91 | InsuletPODD · Health Care | 3.5 | HUF 3.24T | HUF 46,663.69 | 1.96% down | 55% down | ||
| 92 | ZoetisZTS · Health Care | 3.5 | HUF 11.16T | HUF 27,471.83 | 5.59% down | 26% down | ||
| 93 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | HUF 4.2T | HUF 5,042.79 | 1.00% down | 8% up | ||
| 94 | AlconALC · Health Care | 3.4 | HUF 12.17T | HUF 25,332.98 | 1.01% down | 0% up | ||
| 95 | Merit Medical SystemsMMSI · Health Care | 3.3 | HUF 1.72T | HUF 28,702.78 | 1.77% down | 1% up | ||
| 96 | TeleflexTFX · Health Care | 3.3 | HUF 2.2T | HUF 55,562.54 | 1.48% down | 58% up | ||
| 97 | Boston ScientificBSX · Health Care | 3.1 | HUF 21.19T | HUF 14,618.32 | 1.49% down | 55% down | ||
| 98 | Globus MedicalGMED · Health Care | 3.1 | HUF 3.09T | HUF 23,326.74 | 2.74% down | 14% down | ||
| 99 | Legend BiotechLEGN · Health Care | 3.0 | HUF 1.06T | HUF 5,474.64 | 0.92% down | 41% down | ||
| 100 | ChemedCHE · Health Care | 2.8 | HUF 2.43T | HUF 187,474.25 | 0.84% up | 27% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 340.0 HUF). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/S ratio?
Roivant Sciences (3418), Dianthus Therapeutics (2346) and CG Oncology (1811) are the top three of the 154 health care companies ranked by P/S ratio as of 19 Nov 2026, 21:45 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of HUF 3033.56T as of 19 Nov 2026, 21:45 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.